Stock Information
Urogen Pharma Ltd (URGN)
Ticker Symbol: URGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,525.22 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -2.7452
Revenue (TTM): $2.80 M
Dividend Yield: N/A%
ROE: -204.47%
Latest News
-
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
Mon, May 18, 2026 10:42 AM
-
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $45 Price Target
Mon, May 18, 2026 6:29 AM
Key Financials
Financial data not available
